Abbott Hopes To Prevent Heart Failure Hospitalizations With New CardioMEMS HF Labeling

The FDA expanded the indication for Abbott’s CardioMEMS HF wireless heart failure monitor to include patients who have never been hospitalized for heart failure before.

Implantable Pulmonary Pressure Sensor for Abbott's CardioMEMS HF heart failure monitor • Source: Abbott

More from Approvals

More from Policy & Regulation